Antiplatelet use after intracerebral hemorrhage
- 24 January 2006
- journal article
- Published by Ovid Technologies (Wolters Kluwer Health) in Neurology
- Vol. 66 (2), 206-209
- https://doi.org/10.1212/01.wnl.0000194267.09060.77
Abstract
Background: Survivors of intracerebral hemorrhage are at risk for recurrent intracerebral hemorrhage and ischemic cardiovascular and cerebrovascular disease. Objective: To determine whether antiplatelet therapy increases the risk of recurrent intracerebral hemorrhage. Methods: The authors reviewed data from consecutive survivors of primary intracerebral hemorrhage enrolled in a single-center prospective cohort study. Survivors were followed by telephone interview; recurrent intracerebral hemorrhage and post–index antiplatelet agent use and duration were recorded. Cox proportional hazards models was used with antiplatelet agent exposure as a time-dependent variable to assess the effect of antiplatelet agent use on recurrent intracerebral hemorrhage, stratified by lobar and deep hemispheric location. Results: Recurrent intracerebral hemorrhage was more common in survivors of lobar hemorrhage compared with survivors of deep hemorrhage (cumulative 2-year rate 22% vs 4%; p = 0.007). Antiplatelet agents were prescribed in 22% of intracerebral hemorrhage survivors (27/127 lobar, 19/80 deep hemispheric), most commonly for prevention of ischemic heart disease. Antiplatelet agent use was not associated with intracerebral hemorrhage recurrence in survivors of either lobar hemorrhage (hazard ratio [HR] 0.8, 95% CI 0.3 to 2.3, p = 0.73) or of deep hemorrhage (HR 1.2, 95% CI 0.1 to 14.3, p = 0.88). Conclusion: Antiplatelet agent use is relatively common following intracerebral hemorrhage but did not appear to be associated with a large increased risk of intracerebral hemorrhage recurrence in this observational study.This publication has 13 references indexed in Scilit:
- White matter lesions, cognition, and recurrent hemorrhage in lobar intracerebral hemorrhageNeurology, 2004
- Hemorrhage Burden Predicts Recurrent Intracerebral Hemorrhage After Lobar HemorrhageStroke, 2004
- Can Patients Be Anticoagulated After Intracerebral Hemorrhage?Stroke, 2003
- Leukoaraiosis is associated with warfarin-related hemorrhage following ischemic strokeNeurology, 2002
- Genetic and Environmental Risk Factors for Intracerebral HemorrhageStroke, 2002
- Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patientsBMJ, 2002
- Apolipoprotein E Genotype and the Risk of Recurrent Lobar Intracerebral HemorrhageThe New England Journal of Medicine, 2000
- Aspirin and Risk of Hemorrhagic StrokeJAMA, 1998
- Recurrence of Bleeding in Patients With Primary Intracerebral HemorrhageStroke, 1995
- Long-term prognosis of hypertensive intracerebral hemorrhage.Stroke, 1982